8
Total deals
$8.9B
Total value
$1.5B
Avg deal
$4.9B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Alpine Immune Sciences
Alpine Immune Sciences is an immunotherapy company focused on developing treatme…
|
2024-04-10 | Acquisition | Complete | $4.9B | Deal → |
| 2 |
Septerna
Septerna is a biotech firm unlocking diverse drug discovery potential in G prote…
|
2023-09-12 | Acquisition | Complete | — | Deal → |
| 3 |
ViaCyte
ViaCyte is a preclinical therapeutic company specializing in regenerative medici…
|
2022-07-11 | Acquisition | Complete | $320.0M | Deal → |
| 4 |
Vectrus
Vectrus operates as a global government services company.
|
2022-03-07 | Merge | Complete | $2.1B | Deal → |
| 5 |
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 di…
|
2019-09-03 | Acquisition | Complete | $950.0M | Deal → |
| 6 |
Exonics Therapeutics
Exonics Therapeutics, a Boston, Mass.-based biotechnology company.
|
2019-06-06 | Acquisition | Complete | $245.0M | Deal → |
| 7 |
V
ViroChem Pharma
ViroChem Pharma is a privately held company with two investigational HCV polymer…
|
2009-03-12 | Acquisition | Complete | $400.0M | Deal → |
| 8 |
Aurora Biosciences Corporation
Develops and commercializes technologies, products, and services for the discove…
|
2001-04-30 | Acquisition | Complete | — | Deal → |